Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,386 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00431769 | An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma | completed | Phase 2 | 130 | Janssen-Cilag International NVINDUSTRY | 8 | May 12, 2014 | clinicaltrials |
| NCT01471197 | Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer | terminated | Phase 2 | 9 | Bristol-Myers SquibbINDUSTRY | 5 | May 12, 2014 | clinicaltrials |
| NCT01266967 | A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain(Break MB) | completed | Phase 2 | 172 | GlaxoSmithKlineINDUSTRY | 6 | May 8, 2014 | clinicaltrials |
| NCT00579501 | Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma | completed | Phase 2 | 29 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 3 | May 7, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)(ADVANTAGE) | completed | Phase 1 / Phase 2 | 184 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 9 | Apr 30, 2014 | clinicaltrials |
| NCT01105403 | Exploratory Study on POL6326 in Stem Cell Mobilization | completed | Phase 2 | 21 | Polyphor Ltd.INDUSTRY | 1 | Apr 23, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00920140 | Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias | completed | Phase 2 | 97 | GlaxoSmithKlineINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| NCT01272557 | Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial(SoraDox) | unknown | Phase 2 | 170 | PD Dr. med. Matthias DollingerOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT01902862 | An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma | terminated | Phase 2 | 7 | Janssen-Cilag G.m.b.HINDUSTRY | 1 | Apr 1, 2014 | clinicaltrials |
| NCT02007811 | Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination(B-cell therapy) | unknown | Phase 1 / Phase 2 | 15 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00441168 | Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma | terminated | Phase 2 | 30 | Janssen-Cilag International NVINDUSTRY | 7 | Mar 21, 2014 | clinicaltrials |
| NCT00322842 | Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients | completed | Phase 2 | 35 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 13, 2014 | clinicaltrials |
| NCT01594177 | Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy(DAFNE) | completed | Phase 2 | 65 | GBG Forschungs GmbHOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT00543049 | Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor | completed | Phase 2 | 73 | AGO Study GroupOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00615940 | Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer | completed | Phase 2 | 132 | Heidelberg Pharma AGINDUSTRY | 5 | Feb 28, 2014 | clinicaltrials |
| NCT01055522 | Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma | terminated | Phase 2 | 102 | Philogen S.p.A.INDUSTRY | 4 | Feb 25, 2014 | clinicaltrials |
| NCT01058538 | A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours | completed | Phase 1 / Phase 2 | 33 | Philogen S.p.A.INDUSTRY | 2 | Feb 25, 2014 | clinicaltrials |
| NCT00463788 | Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer(BALI-1) | completed | Phase 2 | 181 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 11 | Feb 13, 2014 | clinicaltrials |
| NCT00665314 | Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). | completed | Phase 2 | 5 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00930098 | A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia | completed | Phase 2 | 74 | Genzyme, a Sanofi CompanyINDUSTRY | 6 | Feb 11, 2014 | clinicaltrials |
| NCT00791141 | Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer(ACCRA-HN) | completed | Phase 2 | 80 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00943449 | 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma(Shelter) | completed | Phase 2 | 57 | 4SC AGINDUSTRY | 2 | Jan 16, 2014 | clinicaltrials |
| NCT00425854 | An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer | completed | Phase 2 | 50 | Boehringer IngelheimINDUSTRY | 2 | Dec 31, 2013 | clinicaltrials |
| NCT00984334 | Naloxone SR Capsules in Patients With Opioid Induced Constipation | completed | Phase 2 | 40 | S.L.A. Pharma AGINDUSTRY | 2 | Dec 27, 2013 | clinicaltrials |
| NCT00002803 | Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma | completed | Phase 2 | 44 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00101400 | BAY43-9006 - Phase II in Advanced Breast Cancer | completed | Phase 2 | 54 | BayerINDUSTRY | 2 | Dec 13, 2013 | clinicaltrials |
| NCT01488344 | Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML) | unknown | Phase 1 / Phase 2 | 140 | University Hospital MuensterOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01310816 | A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma | completed | Phase 2 | 105 | Infinity Pharmaceuticals, Inc.INDUSTRY | 13 | Dec 5, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT00431561 | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma | completed | Phase 2 | 141 | Isarna Therapeutics GmbHINDUSTRY | 6 | Dec 3, 2013 | clinicaltrials |
| NCT00883623 | A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis(LEOMEX) | completed | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00661830 | Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) | completed | Phase 2 | 103 | PD Dr Markus MöhlerOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT01388790 | Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer | completed | Phase 2 | 40 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Nov 20, 2013 | clinicaltrials |
| NCT01172769 | Efficacy Study of Temsirolimus to Treat Head and Neck Cancer(TEMHEAD) | completed | Phase 2 | 42 | Hannover Medical SchoolOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00274976 | Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine | completed | Phase 2 | — | German CLL Study GroupOTHER | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00101413 | BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 52 | BayerINDUSTRY | 2 | Oct 30, 2013 | clinicaltrials |
| NCT00320190 | Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib | terminated | Phase 2 | 52 | Bristol-Myers SquibbINDUSTRY | 11 | Oct 30, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT01344902 | An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon | terminated | Phase 1 / Phase 2 | 13 | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT01531764 | BIBW 2992 (Afatinib) and Vinorelbine | terminated | Phase 2 | 2 | University of MagdeburgOTHER | 1 | Oct 18, 2013 | clinicaltrials |
| NCT00044551 | Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 29 | BayerINDUSTRY | 6 | Oct 14, 2013 | clinicaltrials |
| NCT00720850 | Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)(LENAMAINT) | terminated | Phase 2 | 10 | Technische Universität DresdenOTHER | 1 | Sep 27, 2013 | clinicaltrials |
| NCT01035502 | A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia | completed | Phase 2 | 51 | Clavis PharmaINDUSTRY | 4 | Sep 27, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT01945879 | Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 19 | CONKO-StudiengruppeOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00405743 | A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies | completed | Phase 1 / Phase 2 | 153 | Clavis PharmaINDUSTRY | 6 | Sep 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials